MTOR and neoplasm: A main reason for the modest efficacy of mTOR inhibitors may be the pleiotropic activity profile of mTOR characterized by interaction with multiple hallmarks of cancer, such as proliferation, tumor metabolism, and immune response, besides autophagy (28).